8-K: TEAM, Inc. Shareholder Meeting Approves Equity Plan Amendment

TEAM, Inc. shareholders approved an amendment to the 2018 Equity Incentive Plan, increasing available shares by 250,000, and re-elected directors at the 2026 Annual Meeting.

Summary

• TEAM, Inc. held its 2026 Annual Meeting of Shareholders on May 20, 2026.
• Shareholders approved Amendment No. 1 to the Second Amendment and Restatement of the Team, Inc. 2018 Equity Incentive Plan.
• This amendment increases the number of shares available for issuance under the Equity Incentive Plan by 250,000 shares of common stock.
• The Plan Amendment became effective on February 18, 2026, subject to shareholder approval.
• Three Class I directors were re-elected to serve three-year terms.
• Shareholders approved, on an advisory basis, named executive officer compensation for fiscal year 2026.
• The appointment of KPMG LLP as the Company's independent registered public accounting firm for fiscal year 2026 was ratified.
• Shareholders approved the issuance of common stock underlying Stellex Warrants.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this filing as neutral, primarily reporting on routine shareholder meeting outcomes and corporate governance actions without significant new financial information or strategic shifts.

Positives

• Shareholder approval of the equity incentive plan amendment provides additional shares for future equity awards.
• Re-election of all director nominees indicates shareholder confidence in current leadership.
• Ratification of KPMG LLP as independent auditor suggests continued commitment to financial transparency.
• Approval of Stellex Warrant shares issuance facilitates potential future transactions.

Risks

• The Equity Incentive Plan amendment increases the number of shares available for issuance, which could lead to further dilution for existing shareholders if not managed effectively.
• The approval of Stellex Warrant shares issuance, particularly if issued below a 'Minimum Price' or 'Adjustment Floor', could result in dilution and impact shareholder value.

Future Outlook

The filing does not contain specific forward-looking financial guidance. However, the approval of the equity incentive plan amendment and the Stellex Warrant shares issuance suggests potential future equity-based compensation and strategic transactions.

Industry Context

StockSavvy.ai notes that the approval of equity incentive plans is a common practice for public companies to retain and incentivize talent, especially in industries requiring specialized skills. The increase in available shares, while standard, will be closely watched for its impact on dilution.

Corporate Governance

Stakeholder Impact

• Shareholders: Potential for increased dilution due to the equity plan amendment and warrant share issuance, but also continued oversight from re-elected directors.
• Employees: Increased opportunity for equity-based compensation through the expanded incentive plan.
• Management: Continues to operate under the current board and with ratified auditor.

Next Steps

• The re-elected directors will continue their terms until the 2029 Annual Meeting of Shareholders.
• KPMG LLP will serve as the independent registered public accounting firm for the fiscal year ending December 31, 2026.
• The company may now utilize the additional 250,000 shares authorized under the amended Equity Incentive Plan for future grants.
• The company may proceed with the issuance of shares related to the Stellex Warrants.

Key Dates

Keywords

TEAM, Inc., 8-K, Shareholder Meeting, Equity Incentive Plan, Director Election, KPMG LLP, Stellex Warrants, Corporate Governance